Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Rosskopf, Konrad"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 2. Supplementary Materials and Methods.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0286103859570fdda50761d17ced27f7
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 1: Table S1. Tabulation of immunocompromised patients. R-CHOP21—combination chemotherapy consisting of rituximab, cyclophosphamide, vincristine, prednisolone given in 21-day cycles; FOLFOX combination chemotherapy consisting of foli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d23b0b986239869b4e00531e4c1065
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 3: Figure S1. Overall survival of the whole cohort (n = 120). Median follow-up of the whole cohort was 1.9 months (with follow-up truncated at 3 months), we totally observed 52 deaths which corresponds to 1-, 2-, and 3-month OS estima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa67bd3fd4a42c14ba8e897282db6e1d
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 6: Figure S3. Standardized mean difference (SMD) plot. Blue squares denote Standardized mean differences (SMDs) in before weighting the inverse of the probability of treatment weight (IPTW). Yellow diamonds denote the SMDs after weigh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1798ddd8ccfe7ee2f038caa1c79530d1
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 5: Figure S2. Histograms of the Propensity Score and the IPTW. (A) The propensity score can range from 0 to 1. Multiply by 100 to obtain probabilities (in percent) of having received CVP. (B) The IPTW was defined as the inverse of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bbc58c3ee1b059bd16dbe18228baf33
Autor:
Hatzl, Stefan, Posch, Florian, Sareban, Nazanin, Stradner, Martin, Rosskopf, Konrad, Reisinger, Alexander C., Eller, Philipp, Schörghuber, Michael, Toller, Wolfgang, Sloup, Zdenka, Prüller, Florian, Gütl, Katharina, Pilz, Stefan, Rosenkranz, Alexander R., Greinix, Hildegard T., Krause, Robert, Schlenke, Peter, Schilcher, Gernot
Additional file 4: Table S2. Univariable predictors of survival in the cohort (n = 120). BMI: body mass index; first wave: depicts patients treated during the first wave of COVID-19 in Austria between March 2020 and August 2020; mSOFA: modified seque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d08c6855bfd9529ca73272541ada9e9
Autor:
Sperl, Daniela, Lang, Peter, Benesch, Martin, Bainschab, Antonia, Urban, Christian, Wilfing, Roland, Feuchtinger, Tobias, Döring, Michaela, Seitz, Christian, Strenger, Volker, Lackner, Herwig, Seidel, Markus G., Perwein, Thomas, Handgretinger, Rupert, Sipurzynski, Sabine, Rosskopf, Konrad, Schwinger, Wolfgang
Publikováno v:
Pediatric Transplantation; Aug2022, Vol. 26 Issue 5, p1-8, 8p
Autor:
Kovacic Krizanic, Katarina, Prüller, Florian, Rosskopf, Konrad, Payrat, Jean-Marc, Andresen, Silke, Schlenke, Peter
Publikováno v:
Pathogens; Jul2022, Vol. 11 Issue 7, pN.PAG-N.PAG, 10p